We explored the feasibility of using the APTW signal intensity as a surrogate biomarker to identify the methylation status of MGMT promoter in glioblastoma (GBM). Eighteen patients with newly diagnosed GBM were recruited and scanned. Results showed that the APTW signal intensities were significantly higher in the unmethylated MGMT promoter group than in the methylated MGMT promoter group. The area under the ROC curve (AUC) for APTW to differentiate these two GBM groups was 0.857. Preoperative APTW imaging may assist in predicting the MGMT promoter methylation status in patients with GBM.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords